ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
75 hedge funds and large institutions have $18.4M invested in Endocyte, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 28 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
68% less call options, than puts
Call options by funds: $147K | Put options by funds: $457K
Holders
75
Holding in Top 10
–
Calls
$147K
Puts
$457K
Top Buyers
| 1 | +$664K | |
| 2 | +$648K | |
| 3 | +$591K | |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$287K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$273K |
Top Sellers
| 1 | -$2.48M | |
| 2 | -$958K | |
| 3 | -$553K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$477K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$454K |